Scanadu raises $35M in Series B funding

What does Scanadu do?

Scanadu,is medical technology startup which develops devices which allows users for tracking and monitoring their health.  It brings a suite of product of health diagnostics to market which enable consumers to diagnose better many common ailments with the capacity of monitoring and measuring the health. The Scanadu is an early stage company which is developing a suite of consumer medical device products which uses science and power of technology which will help you monitor your health anywhere and at anytime. Every product of Scanadu is designed to wirelessly and effortlessly connect to the user’s smart phone and provides them with the intelligence and analytics for living a healthier life.

How much Scanadu was funded?

Scanadu raised $35M in Series B funding on April 27^th, 2015 from the investors Three Leaf Ventures, Redmile Group, AME Cloud Ventures, Tencent Holdings, Relay Ventures and CBC Capital and other angel investors.

Previous funding

• $2M in Seed funding on November 8, 2011.
• $1.6M in Product Crowdfunding on June 9, 2013
• $10.5M in Series A funding on November 12, 2013 from Farzad (Zod) Nazem, Redmile Group, Three Leaf Ventures, Relay Ventures, Mindful Investors and AME Cloud Ventures.

What is next for Scanadu?

Scanadu has raised $49.7M in total funding to date with the lastest round of funding.  This medtech company is building a family of mobile medical products for customers. It has plans to use the latest fund to take its vision of putting the diagnostic power of a hospital in the smart phones, a step further. Scanadu mission is to give 8 billion people an access to quality healthcare through their smart phones.

More about Scanadu?

Scanadu was founded in January, 2011 by Sam De Brouwer, Misha Chellam and Walter De Brouwer. It has its headquarters in Mountain View, CA.